Lichter Jay

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 32% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 833%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Lichter Jay's trades of Janux Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-01 2024-11-01
PrS Proposed sale
34,355
459.24
US$2,062,818 		34,355 459.24 US$2,062,818
2024-10-28 2024-10-28
PrS Proposed sale
11,446
292.21
US$2,329,318 		11,446 292.21 US$2,329,318
2024-10-24 2024-10-24
PrS Proposed sale
9,769
224.29
US$1,156,708 		9,769 224.29 US$1,156,708
2024-10-21 2024-10-21
PrS Proposed sale
2,434
49.49
US$120,454 		2,434 49.49 US$120,454
2024-10-17 2024-10-17
PrS Proposed sale
1,842
50.05
US$92,193 		1,842 50.05 US$92,193
2024-10-16 2024-10-16
PrS Proposed sale
10,957
50.80
US$556,599 		10,957 50.80 US$556,599
2024-09-27 2024-09-27
PrS Proposed sale
1,826
46.19
US$84,335 		1,826 46.19 US$84,335
2024-10-24 2024-09-13
S Sale
3,815 -35.3%
46.68
US$178,084 		3,815 -35.3% 46.68 US$178,084
2024-09-13 2024-09-13
PrS Proposed sale
3,815
46.68
US$178,084 		3,815 46.68 US$178,084
2024-09-09 2024-09-09
PrS Proposed sale
2,182
42.33
US$92,369 		2,182 42.33 US$92,369
2024-06-05 2024-06-03
S Sale
691,525 -17.2%
54.75
US$37,860,994 		691,525 -17.2% 54.75 US$37,860,994
2024-06-05 2024-06-03
S Sale
131,196 -17.2%
54.75
US$7,182,981 		131,196 -17.2% 54.75 US$7,182,981
2024-06-05 2024-06-03
S Sale
677,279 -17.2%
54.75
US$37,081,025 		677,279 -17.2% 54.75 US$37,081,025
2023-11-15 2023-11-13
B Purchase
849,854 +inf%
5.87
US$4,988,643 		849,854 +inf% 5.87 US$4,988,643
2021-03-03 2021-03-03
US Otonomy Inc (OTIC)
S Sale
113,935 -100.0%
2.70
US$307,397 		113,935 -100.0% 2.70 US$307,397
2021-03-03 2021-03-03
US Otonomy Inc (OTIC)
S Sale
207,245 -100.0%
2.70
US$559,147 		207,245 -100.0% 2.70 US$559,147
2021-03-02 2021-03-02
US Otonomy Inc (OTIC)
S Sale
138,199 -54.8%
2.90
US$400,639 		138,199 -54.8% 2.90 US$400,639
2021-03-02 2021-03-02
US Otonomy Inc (OTIC)
S Sale
251,375 -54.8%
2.90
US$728,736 		251,375 -54.8% 2.90 US$728,736
2021-03-02 2021-03-01
US Otonomy Inc (OTIC)
S Sale
61,619 -19.6%
2.86
US$175,984 		61,619 -19.6% 2.86 US$175,984
2021-03-02 2021-03-01
US Otonomy Inc (OTIC)
S Sale
112,081 -19.6%
2.86
US$320,103 		112,081 -19.6% 2.86 US$320,103
2021-03-02 2021-02-26
US Otonomy Inc (OTIC)
S Sale
117,262 -27.2%
2.83
US$331,851 		117,262 -27.2% 2.83 US$331,851
2021-03-02 2021-02-26
US Otonomy Inc (OTIC)
S Sale
213,292 -27.2%
2.83
US$603,616 		213,292 -27.2% 2.83 US$603,616
2021-02-25 2021-02-25
US Otonomy Inc (OTIC)
S Sale
110,361 -20.4%
2.95
US$326,006 		110,361 -20.4% 2.95 US$326,006
2021-02-25 2021-02-25
US Otonomy Inc (OTIC)
S Sale
200,739 -20.4%
2.95
US$592,983 		200,739 -20.4% 2.95 US$592,983
2021-02-25 2021-02-24
US Otonomy Inc (OTIC)
S Sale
178,484 -24.8%
2.98
US$532,239 		178,484 -24.8% 2.98 US$532,239
2021-02-25 2021-02-24
US Otonomy Inc (OTIC)
S Sale
324,651 -24.8%
2.98
US$968,109 		324,651 -24.8% 2.98 US$968,109
2021-02-25 2021-02-23
US Otonomy Inc (OTIC)
S Sale
95,113 -11.7%
2.89
US$274,686 		95,113 -11.7% 2.89 US$274,686
2021-02-25 2021-02-23
US Otonomy Inc (OTIC)
S Sale
173,005 -11.7%
2.89
US$499,638 		173,005 -11.7% 2.89 US$499,638